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The emergence of terpene cyclization was critical to the evolutionary expansion of chemical
diversity yet remains unexplored. Here we report the ﬁrst discovery of an epistatic network of
residues that controls the onset of terpene cyclization in Artemisia annua. We begin with
amorpha-4,11-diene synthase (ADS) and (E)-b-farnesene synthase (BFS), a pair of terpene
synthases that produce cyclic or linear terpenes, respectively. A library ofB27,000 enzymes
is generated by breeding combinations of natural amino-acid substitutions from the cyclic
into the linear producer. We discover one dominant mutation is sufﬁcient to activate
cyclization, and together with two additional residues comprise a network of strongly epistatic
interactions that activate, suppress or reactivate cyclization. Remarkably, this epistatic
network of equivalent residues also controls cyclization in a BFS homologue from Citrus junos.
Fitness landscape analysis of mutational trajectories provides quantitative insights into a
major epoch in specialized metabolism.
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T
he emergence of novel catalytic function underlies the
evolutionary expansion of metabolism with profound
biological implications1. Ring-forming reactions
(cyclization) catalysed by terpene synthases (TPSs) were central
to this expansion, giving rise to cyclic terpenes, the most diverse
family of specialized (secondary) metabolites. Cyclic terpenes
mediate essential interactions between organisms, enabling plants
to attract pollinators2 and natural enemies of herbivores3, repel
microbial pathogens4, and to conduct symbiotic relations5. They
also provide a rich source of bioactive compounds for human
uses ranging from ﬂavours and fragrances to medicinal
compounds such as artemisinin, a naturally occurring terpenoid
extracted from Artemisia annua, the most effective treatment for
malaria6. However, despite the intensive study of the TPS enzyme
family, little is known about the evolutionary emergence of the
cyclization mechanism.
Cyclization is the major gateway to chemical diversity in
isoprenoid specialized metabolism; TPSs convert a few universal
substrates into hundreds of often stereochemically complex
mono- and polycyclic hydrocarbons7, which seed the
biosynthesis of thousands of derivatives through downstream
metabolic pathways. The conserved class I terpenoid synthase
fold, as revealed from the ﬁrst crystal structures8,9, has evolved
the unique catalytic function of cyclization, converting C-10,
C-15 and C-20 isoprenyl diphosphate substrates into mono-,
sesqui- and diterpenes, respectively. TPS-catalysed reactions can
achieve extraordinary mechanistic complexity, often involving
numerous electrophilic cyclizations and rearrangements
according to well-established chemical rules10,11, stemming
from intrinsic and induced chemical reactivity12. In A. annua,
amorpha-4,11-diene synthase (ADS) catalyses a multi-step
electrophilic reaction that converts the C-15 sesquiterpene
substrate farnesyl pyrophosphate (FPP) into amorpha-4,11-
diene, the bicyclic hydrocarbon precursor of artemisinin. By
contrast, (E)-b-farnesene synthase (BFS) catalyses one of the
simplest TPS reactions where the linear carbocation is quenched
before cyclization can happen; formally, this involves release of
pyrophosphate followed by proton elimination from either a
transoid or cisoid farnesyl carbocation to produce the linear
hydrocarbon (E)-b-farnesene, an aphid alarm pheromone13.
Isotope labelling studies suggest that isomerization via a tertiary
diphosphate intermediate (nerolidyl diphosphate) may be a more
general feature of all 1,4-conjugate elimination reactions catalysed
by terpene synthases like BFS14,15.
From an evolutionary perspective, the emergence of the
cyclization mechanism was a critical and deﬁning step of the
TPS family, essential for the biogenesis of structurally complex
metabolites. While the activities of the earliest TPSs are unknown,
the modern TPSs (both linear and cyclic terpene producers) likely
arose by numerous distinct paths. According to one possible
scenario, a ‘minimalist’ class of enzymes like BFS preceded
the more ‘complex’ functions of ADS, thereby involving a gain
of cyclization function mutation(s) to unlock ring-forming
catalytic activities. To a ﬁrst approximation, natural variation at
positions within the active site and surrounding regions of the
protein structure would most strongly inﬂuence the onset of
cyclization. Thus, identiﬁcation of key substitutions that unlock
cyclization may provide fundamental structural insights and
mechanistic clues about how ring formation evolved and hence a
basis to explore this phenomenon in the greater TPS family from
plants to microbes.
To investigate the emergence of terpene cyclization, we initially
focus on the TPS enzymes of A. annua. We use structure-based
combinatorial protein engineering (SCOPE)16 to breed natural
variation from ADS into the background of BFS, two related
enzymes that share 49% amino-acid identity. Through successive
rounds of screening, we identify a dominant mutation that
activates cyclization in BFS, and uncover additional mutations
that form an extended epistatic network that is able to activate,
suppress or reactivate cyclization. We further demonstrate this
residue network is able to activate cyclization in a BFS homologue
from Citrus junos. Finally, we calculate the ﬁtness landscapes of
A. annua and C. junos to directly measure how the protein
background shapes the functional roles and pattern of epistatic
interactions among residues in the network. These results provide
unique insights into the emergence of cyclization across distinct
plant lineages that underlie the evolutionary expansion of
specialized metabolism.
Results
Breeding natural mutations from ADS into BFS. The A. annua
TPSs provide an ideal starting point to experimentally examine
the critical structural features underlying the emergence of
cyclization, given the contrasting mechanisms of BFS and ADS
(Fig. 1). To identify candidate amino-acid substitutions to
incorporate into BFS, we mapped the variable sequence positions
between ADS and BFS onto structural models. Through
sequence-structure analysis, we localized 24 substitutions within a
6-angstrom radius of the active site centre, which included
5 second-tier positions and 3 positions in a ﬂexible loop that caps
the active site (Fig. 2a,b). A complete library encoding this
combinatorial complexity would total 224 mutants (that is,
16,777,216). We anticipated that the active site would potentially
require signiﬁcant remodelling to accommodate cyclization;
therefore, we designed our library to sample multiple mutational
combinations simultaneously in the active site. Given technical
limitations to screening throughput (discussed below), we
designed oligonucleotides to encode a subset of combinations
yielding 27,524 theoretically possible mutations (Supplementary
Figs 1 and 2; Supplementary Tables 1 and 2). We used structure-
based combinatorial protein engineering (SCOPE)16,17 to breed
this diversity into BFS and create a gene library as nine discrete
collections (B3,000 distinct variants each). Each collection
contained varying numbers of mutations, ranging from 2–5 to
7–11 positions mutated simultaneously. We conducted three
rounds of screening, sampling individual mutants from each
collection (totalling 754 mutants). By synthesizing the library as
unique subsets, we signiﬁcantly enhanced screening
probabilities16, which also gave us ﬂexibility to shift sampling
intensity among different collections and further partition our
library into subpopulations in response to screening results
(described below).
Discovery of a dominant mutation that activates cyclization.
To identify cyclization activities in our libraries, we used gas
chromatography-mass spectrometry (GC–MS). While GC–MS is
a low-throughput analytical technique, which imposed limitations
on the numbers of mutants we were able to characterize in our
screening efforts (B20min per run), it enables resolution of
hydrocarbon products and unambiguous identiﬁcation of cyclic
terpenes. To biochemically characterize mutant enzymes, we
sampled B32 mutants from each of the nine mutant pools (282
mutants), expressed recombinant proteins in E. coli and assayed
puriﬁed enzymes by GC–MS (Fig. 2c and Supplementary Fig. 3).
Finally, we sequenced selected clones, veriﬁed activities and
measured the kinetic properties of the encoded proteins18
(Supplementary Table 3).
From our initial screen of 282 BFS mutants, most clones
produced soluble protein. However, 94% of mutants were
inactive, while 5% retained BFS WT-like farnesene synthase
activity (Supplementary Fig. 4). Signiﬁcantly, we identiﬁed three
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mutants (1%) that produced multiple cyclic terpene products
(Supplementary Table 4a). Following sequence analysis, further
mutagenesis and screening we identiﬁed Y402L as a single
common substitution among cyclic terpene-producing enzymes.
Incorporating the single Y402L substitution into wild-type
BFS was sufﬁcient to induce the production of 15 distinct
cyclic terpenes comprising B75% of enzyme-catalysed products,
including 1.3% of a putative amorphane sesquiterpene (Fig. 3b,f).
We further characterized Y402L by steady-state kinetic measure-
ments, revealing that catalytic efﬁciency was only slightly reduced
(kcat/KM¼ 10.5 10 3 versus 5.9 10 3 mM 1 s 1 for BFS
WT and Y402L, respectively) (Table 1). Consequently, removing
the Y402L mutation abolished cyclization and the three cyclic
terpene-producing mutants reverted to enzymes with BFS WT-
like product speciﬁcity. This result demonstrates that the single
Y402L is a dominant natural mutation that provides a viable
gateway to cyclization in A. annua BFS.
Our discovery of the Y402L mutation prompted us to screen
for more functionally diverse cyclases in the Y402L background
and to search for an alternative position(s) that may activate
cyclization in the wild-type (Y402) background. We also
identiﬁed a deleterious mutation G296C prevalent among inactive
mutants in our initial screen. Therefore, we removed G296C and
split our libraries into subsets containing either the Y402L
mutation or the wild-type (Y402) background and conducted a
second round of screening (Supplementary Table 4a). Through-
out our screening, we shifted sampling intensity to library subsets
that yielded the highest number of active clones. In total, we
sampled 142 mutants from the wild-type background (Y402)
group, where all 25 active mutants (18%) maintained wild-type
BFS product speciﬁcity. This result suggests that cyclization was
Y402L-dependent among the diversity that we screened. In the
Y402L group (321 mutants), we found a similar percentage (15%)
of active mutants (47) with 37 unique mutants that produced
multiple (8 to 15) cyclic products. While the vast majority of
cyclases were promiscuous, (Supplementary Figs 5 and 6; and
Supplementary Tables 5 and 6a), we discovered three mutants
with moderate product speciﬁcity (B50% single product)—an a-
bisabolol synthase (BOS), a b-bisabolene synthase and a cis-a-
bergamotene synthase (Supplementary Fig. 7).
To further test the dominance of position 402, we added or
removed Y402L from a set of 18 mutants identiﬁed in our second
screen (Supplementary Table 6). Y402L consistently activated
cyclization (by increasing cyclic products by 15-fold from an
average of 4 to 58%) across different BFS mutants, each mutant
enzyme producing a wide distribution of cyclic products.
Conversely, removing Y402L reverted all cyclases to non-
cyclizing variants of BFS. Enzyme turnover (kcat apparent) was
also minimally affected by the addition of Y402L (with an average
reduction of 1.5%), which indicates that this mutation is well
tolerated in the context of other mutations and primarily affects
product speciﬁcity (Supplementary Table 8). Taken together,
these results suggest a potential role for Y402L as a dominant
mutation in the functional divergence of TPSs in A. annua.
An epistatic network controls cyclization. Though Y402L was
essential to activate cyclization, we discovered 10 WT-like BFS
enzymes in the Y402L background from our second screen,
indicating the presence of substitutions that suppress cyclization.
Among these, we identiﬁed a single common substitution
(V467G) that was sufﬁcient to revert cyclase mutants to
farnesene-producing synthases (Fig. 3c). The V467G mutation
also had deleterious effects on catalytic efﬁciency (B10-fold
reduction in the Y402L/V467G double mutant; Table 1). To
evaluate the strength of suppression, we incorporated the V467G
mutation into a collection of 10 cyclases (Y402L background)
from our second screen. All mutants showed a 4.5-fold decrease
in cyclization from an average of 59 to 13% cyclic products.
Consequently, removing the V467G mutation from a set of ﬁve
linear terpene-producing mutants in the Y402L background
resulted in a sixfold increase in cyclization from an average of 9 to
55% cyclic products (Supplementary Table 9). Therefore, the
V467G mutation displays an epistatic (masking) effect on the
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Figure 1 | Catalytic mechanisms of TPS enzymes. Terpene synthases are carbon-oxygen lyases as illustrated by the core sesquiterpene synthase
mechanism (overview inset). TPSs catalyse the metal-dependent cleavage (ionization) of the carbon-oxygen bond of isoprenoid pyrophosphate substrates,
such as the 15-carbon farnesyl pyrophosphate (FPP) leading to numerous potential outcomes. In the BFS-catalysed mechanism, deprotonation of the
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Numbers in parentheses above arrows indicate cyclization steps. Cyclization commences from either the transoid or cisoid farnesyl cations (red), bridged
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isomerization, where either 1,6 or 1,10 cyclization pathways (light yellow spheres) lead to energetically viable rearrangement pathways49 before converging
on the amorpha-4,11-diene ﬁnal product.
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Y402L cyclization phenotype according to the classical deﬁnition
introduced by Bateson19.
To identify additional layers of epistatic interactions, we
examined our data set and found a natural substitution (Y430A),
which overcame second-site suppression by V467G. While the
single Y430A substitution alone was unable to activate cyclization
in the parent BFS, incorporation of Y430A into the suppressed
background (Y402L/V467G) restored cyclization to a total of 55%
without impacting catalytic efﬁciency (kcat/KM¼ 0.9 10 3
mM 1 s 1) relative to the Y402L/V467G double mutant
(Fig. 3d and Table 1). Introduction of the Y430A substitution
into seven different Y402L/V467G mutant backgrounds repeatedly
stimulated cyclization fourfold from an average of 9 to 37% cyclic
products (Supplementary Table 10). Interestingly, pairing Y430A
with Y402L both stimulated production of cyclic products to 87%
and enhanced catalytic efﬁciency relative to the single Y402L
mutation (kcat/KM¼ 7.1 10 3 mM 1 s 1) (Fig. 3e and Table 1).
This result suggests that the Y402L/Y430A pair of substitutions
may have been early critical steps in the emergence of robust
cyclase activity in A. annua. While previous investigations have
shown that epistatic interactions modulate downstream cyclization
rearrangements20, the current work reveals that positions 402-467-
430 form a strongly epistatic residue network that coordinately
controls the onset of cyclization, the deﬁning catalytic function of
the TPS enzyme family.
The order of mutational steps can have a profound effect on
the acquisition or disappearance of novel or existing traits, as
exempliﬁed by studies of protein evolution in antibiotic
resistance21. To consider the functional consequences of
alternative mutational pathways, we constructed the genotypic
space formed by the 402-467-430 epistatic network, represented
as a cube of 23¼ 8 genotypic states (Fig. 4a). While farnesene
synthase speciﬁcity persists along the top plane, one can trace a
hypothetical path from wild-type BFS to the triple mutant where
activity oscillates between linear and cyclic products; cyclization
can be activated by the dominant mutation (Y402L), suppressed
by addition of a second-site suppressor mutation (Y402L, V467G)
and reactivated from a suppressed state (Y402L, V467G, Y430A).
Under alternative scenarios, early acquisition of V467G blocks
cyclization while initial drift to Y430A primes BFS to become a
catalytically robust cyclase on subsequent acquisition of the
Y402L mutation.
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Figure 2 | Design and synthesis of BFS gene library. (a) A phylogenetic tree was constructed using full-length mono- and sesquiterpene synthase
protein sequences from Artemisia annua, where the bar at the bottom of the tree corresponds to sequence relatedness. (b) Superimposed structural models of
BFS (yellow) and ADS (blue) illustrate the conserved terpenoid synthase fold. Identiﬁcation of variable residues between BFS and ADS within a 6Å sphere of
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fragments in nine discrete pools (grid) was accomplished via structure-based combinatorial engineering (SCOPE) to assort mutation at low (L),
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Grouping nodes of the genotype space according to shared
phenotypes suggests that this network forms a ‘fracture plane’ in
sequence space at the boundary of emergent catalytic function
(Fig. 4a). To assess the catalytic efﬁciency along the fracture
plane, we measured the turnover number (kcat apparent) of 98
mutant enzymes from our collective screening and mutagenesis
studies (Fig. 4b and Supplementary Table 3). A considerable
fraction of mutants (15%) had catalytic properties comparable to
native enzymes from other species (deﬁned as the activity of
Citrus junos BFS with a kcat apparent of 0.075 s 1), particularly in
the Y402L background. More generally, however, accumulating
numbers of mutations led to an exponential decline in catalytic
efﬁciency (Supplementary Fig. 8), indicating that a restricted
subset of viable mutational pathways extend from the Y402L
mutation to diverse cyclase activities.
Structural interpretation of the cyclization mechanism. Struc-
tural models provide a basis to rationalize how the Y402L
mutation may control the cyclization mechanism (Fig. 5a). To
achieve the observed spectrum of cyclic products observed in BFS
mutant backgrounds (Fig. 3), Y402L must both delay proton
elimination and unlock the all trans FPP substrate to precisely
align the ligand for cyclization along the 1,6 cyclization pathway
(Fig. 5b). The close proximity of Y402L to the pyrophosphate and
the ﬁrst isoprene unit of FPP—the site of these key chemical
transformations—suggests this residue is well-positioned to
inﬂuence proton elimination, pyrophosphate ionization/recapture
and 2,3 s-bond rotation in the neutral NPP intermediate of BFS-
catalysed reactions14 (Fig. 5a). Steric effects likely dominate, as
substitution of Y402 with other aromatic residues (Phe and Trp)
preserves farnesene synthase activity, while smaller aliphatic
residues (Leu, Ile, Val and Thr) activate cyclization, perhaps by
creating additional space for isomerization to happen more freely
(Supplementary Table 7).
The physical basis for the epistatic interactions among residues
of the 402-467-430 network is less obvious from models alone.
The close proximity of positions Y430 to V467 suggests that these
residues may interact directly, which accounts for Y430A
reactivating cyclization from the V467G-suppressed background.
Intriguingly, position V467 is B10 A˚ away from Y402 in our
structural model, adjacent to the last isoprene unit, yet exerts a
profound suppressive effect on cyclization. Ultimately, the
antagonistic interaction between position 402 and 467 must be
transmitted either through a network of intervening amino-acid
residues in the protein, through the isoprenoid chain of the
bound FPP ligand or both (Fig. 5a).
Phylogenetic context of the epistatic network. To interpret our
discoveries in an evolutionary context, we conducted a phyloge-
netic analysis of the plant TPSs family. Examination of the data
revealed that tyrosine is the ancestral state at position 402, con-
served across the plant TPS-a subgroup for which the A. annua
TPSs are cognate members (Supplementary Fig. 9). This obser-
vation suggests that the Y402L substitution was a recent event in
A. annua and implicates Y402L as a dominant mutation in the
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Figure 3 | Cyclic terpene product diversity synthesized by mutants of the
BFS 6Å library. Total ion chromatograms of (a) the wild-type (WT);
(b) the dominant mutant Y402L, (c) the second-site revertant mutant
Y402L/V467G, (d) the re-activated cyclic mutant Y402L/V467G/Y430A
and (e) the super cyclase Y402L/Y430A are shown; linear products are
indicated with a yellow line, all other products are cyclic. (f) A reaction
scheme illustrates the cyclization pathways leading to product diversity
observed in BFS mutants (blue circles) from rearrangements (light yellow
circles) via the bisabolyl cation (orange circle). Mechanisms for linear
product formation (10, a-farnesene; 17, nerolidol; and 20, farnesol) are not
shown. (g) An annotated reference total ion chromatogram (Y402L).
Labelled peaks and chemical structures were identiﬁed either by MS
comparisons with authentic standards or matched to reference mass
spectral databases (Supplementary Fig. 5 and Supplementary Table 5).
Products of BFS mutants (blue circles, and also labelled in the total ion
chromatogram) are 1, sesquithujene; 2, a-exo-bergamotene; 3, Peak 1;
4, (E)-b-farnesene; 5, putative amorphadiene isomer; 6, g-curcumene;
7, ar-curcumene; 8, cis-a-bergamotene; 9, zingiberene; 10, a-farnesene; 11,
b-bisabolene; 12, b-curcumene; 13, Peak 2; 14, b-sesquiphelladrene; 15,
Peak 3; 16, a-bisabolene; 17, nerolidol; 18, Peak 4; 19, a-bisabolol; 20,
farnesol. Mechanistically related products from A. annua (green circles) are
21, a-cedrene; 22, acoradiene; 23, 8-epi-cedrol.
Table 1 | Steady-state kinetic parameters for selected
mutants along a mutation path of the epistatic cube.
Name Km (lM) kcat (s 1) kcat/Km (lM 1 s 1)
BFS (WT) 16.19 0.170 10.5 10 3
Y402L 10.57 0.062 5.9 10 3
Y402L/V467G 5.99 0.005 0.8 10 3
Y402L/V467G/Y430A 4.27 0.004 0.9 10 3
Y402L/Y430A 5.22 0.037 7.1 10 3
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evolutionary emergence of amorpha-4,11-diene and a-bisabolol
biosynthesis, as both known dedicated TPSs contain this sub-
stitution. Consistent with this, most Y402L-contating BFS
mutants in our library produce detectable amounts (B3%) of a
putative amorphadiene isomer while one mutant produces a-
bisabolol as the main product (61%). Considering the opposite
scenario, we investigated the capacity of position 402 to suppress
cyclization in ADS. While incorporating the L402Y mutation into
ADS induced a broadening of cyclization products (from 94 to
82% amorpha-4,11-diene in the mutant), the more marked effect
was on catalytic efﬁciency that was reduced by 44%
(Supplementary Fig. 10). This result suggests that mutation back
to the ancestral state was blocked by epistatic constraints, as
numerous additional mutations undoubtedly contribute to the
high-ﬁdelity synthesis of amorpha-4,11-diene by ADS. Similar
effects have been noted in evolving glucocorticoid receptors22 and
are likely due to incompatibility from additional accumulating
substitutions among divergent homologues23.
In a broader evolutionary context, the terpenoid synthase fold
remains constant and hence the spatial positions of the 402-467-
430 network residues remain essentially ﬁxed. This raises an
intriguing question of how a changing protein background
inﬂuences interactions between positions within the network and
their capacity to activate the cyclization mechanism. To explore
this, we introduced substitutions into the equivalent positions of
C. junos BFS from the Rutaceae plant family, the closest related
homologue to A. annua BFS with 51% amino-acid sequence
identity. Strikingly, G467V is able to activate cyclization; in
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along a fracture plane separating linear from cyclic activities. (b) The impact of additional mutations on the 402-467-430 residue network was plotted to
show production of cyclic products versus turnover number (kcat apparent). The data were grouped according to the eight nodes shown in panel a. Yellow
and green points denote linear, while blue points denote cyclic product-producing mutants.
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C. junos G467V induces production of 15 distinct cyclic terpenes
comprising 53% total product (Supplementary Fig. 11). Numer-
ous cyclic products of C. junos G467V match those we previously
identiﬁed for A. annua Y402L cyclases, indicating that cyclization
proceeds via a common cisoid cyclization pathway (Fig. 1 and
Fig. 3f). Importantly, G467V in C. junos maintains native-like
catalytic efﬁciency (kcat/KM¼ 2.4 versus 1.4 mM 1 s 1 for WT
and G467V, respectively), indicating a viable pathway to
cyclization (Fig. 4b). By contrast, position 402 alone has no
impact on cyclization in the C. junos homologue, although
pairing with position 430 promotes cyclization as seen in
A. annua BFS (Supplementary Table 11). This result clearly
demonstrates the capacity of the 402-467-430 network to control
the onset of cyclization in a BFS homologue, while the changing
protein background causes a marked shift in the functional
contribution of individual positions.
Though qualitatively evident, we sought to quantify epistasis in
A. annua and C. junos BFS backgrounds24,25. Therefore, we
calculated the roughness (degree of epistasis) of the minimal
ﬁtness landscapes for the 402-467-430 network using %
cyclization activity as a proxy for ﬁtness (Table 2,
Supplementary Table 12). Globally, the A. annua landscape was
smooth (r/s¼ 0.57) relative to other enzyme systems26, indicating
many accessible pathways to cyclization24–26. However, the
roughness of the C. junos landscape increased 1.5-fold
(r/s¼ 0.87), signifying a highly epistatic landscape and greater
constraint on the emergence of cyclization in this protein
background. To visualize epistasis, we plotted the relative
ﬁtness of all possible mutational paths across each landscape
(Fig. 6). Immediately apparent is that both A. annua and C. junos
networks are severely distorted as compared with the idealized
additive (non epistatic) landscape, reﬂecting the strong epistatic
character. Further, the pattern of epistatic interactions is clearly
different among residues in the 402-467-430 network in each
protein, providing a measure of the unique contribution of the
protein background. Formally, mutations at positions 402-430
represent ﬁtness maxima in both landscapes, appearing as global
or local maxima in A. annua and C. junos, respectively. Our
analysis thus reveals how interaction among residues in the 402-
467-430 network, particularly the 402-430 pair, likely made a
profound contribution to the emergence of cyclization in different
protein backgrounds.
Discussion
The implications of our ﬁndings paint a picture of epochal
evolution in TPSs. In one possible scenario, a simple primordial
BFS activity persisted while cyclization potential was continually
changing via neutral drift27 as genes spread across different plant
lineages, seeding chemodiversity to come. Then, at different times
and in distinct lineages, cyclization was activated by a dominant
mutation within a common epistatic network, analogous to driver
nodes controlling emergent properties in complex systems28. The
activities of the resulting, likely promiscuous, cyclase progenitor
could be further honed by natural selection or reﬁned by protein
engineering29. The former, natural process, likely shaped a subset
of TPSs in A. annua giving rise to amorpha-4,11-diene and a-
bisabolol synthase speciﬁcities. Alternatively, one could envision a
convergent evolution scenario wherein different species acquired
a BFS activity via mutations that derail cyclization to linear
products, as observed in bacterial TPSs15,30. To a plant, this trait
may confer an advantage in warding off aphids given their highly
tuned chemoreceptor for the alarm pheromone (E)-b-
farnesene31, suggesting an antagonistic co-evolutionary link
between insects and plants. In either scenario, a dominant
mutation within an epistatic network of residues in the conserved
protein fold likely drove transitions between simple and complex
traits in TPSs, ultimately controlling the ﬂow of chemical signals
between organisms.
An intriguing ﬁnding in this report is the strength of
interactions between distant positions in protein structure that
result in the masking and unmasking of the cyclization
mechanism. Distant effects have been observed in directed
evolution experiments23,32, consistent with energetically coupled
residues in protein structure33 and long range communication by
Table 2 | Fitness landscape properties for A. annua and
C. junos.
Landscape property A. annua C. junos
Roughness (r) 7.792 0.567
Mean slope(s) 13.64 0.651
Roughness to mean slope ratio (r/s) 0.571 0.871
Correlation coefﬁcient 0.873 0.760
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Methods).
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allosteric interactions34. More interesting is the implication that
epistatic interactions may be transmitted through the ligand,
involving conformational re-organization of the isoprenoid chain
between locked and unlocked states—the ﬁrst such suggestion to
our knowledge.
The preservation of epistatic linkage in the 402-467-430
network in distinct BFS backgrounds suggests that we have
uncovered an intrinsic feature of the terpene synthase fold. We
posit that such epistatic networks may be modular and serve as
discrete control elements in protein structure akin to protein
sectors35. Therefore, the approaches presented here could be
exploited to empirically deﬁne epistatic networks through
directed enzyme breeding guided by structural and phylogenetic
information. Extracted networks in turn could be exploited in
protein engineering applications. For example, the 402-467-430
network may activate isomerization in transoid TPS backgrounds
and thereby redirect major cyclization pathways to access
otherwise dormant cisoid cyclization pathways36 (Fig. 1). More
generally, we suggest that activating or suppressing a speciﬁc
catalytic function by transferring epistatic networks between
homologues could be exploited in protein engineering
applications to drive synthetic biology efforts for industrial and
pharmaceutical biotechnology applications.
Methods
Homology modelling of BFS and ADS protein structures. Homology models
were generated by submitting full-length amino-acid sequences to the I-TASSER
server37,38. Substrate docking was carried out using AutoDock Vina39.
Comparative sequence-structure analysis for the design of the BFS library
(24 amino-acid substitutions within a 6-angstrom radius of the active site) and
protein structure ﬁgures were generated using UCSF Chimera v.1.8.1 (ref. 40).
Gene deconstruction and 3-plasmid system cloning. The BFS gene was
deconstructed into three gene fragments for mutagenesis and library construction.
Gene fragments were ampliﬁed by PCR using a full-length cDNA clone BFS-
pH9GW as a template. PCR was carried out using Phusion High-Fidelity poly-
merase (New England Biolabs) for 30 cycles (program: 98 C, 20 s, 50 C, 30 s,
72 C, 30 s and ﬁnal extension at 72 C, 10min). The N-terminal, central and
C-terminal fragments were ligated into pBSK2, pVL1392 and pcDNA plasmids,
respectively, followed by transformation into DH5a Library Efﬁciency cells (Life
Technologies).
Mutagenesis of plasmid library and full-length genes. The 24 mutations were
localized in six regions (zones) of the protein sequence. Each gene fragment (N-
terminal, central and C-terminal) contained two zones and primers were designed
to incorporate mutational combinations into each zone (Supplementary Fig. 1).
Complementary primers were designed according to the QuikChange Site-Directed
Mutagenesis Kit Instruction Manual (Stratagene). Non-overlapping primers were
designed according to Liu and Naismith41 and synthesized by Sigma Aldrich;
forward and reverse primers were diluted to 10mM and mixed in a 1:1 ratio. All
primers and their Tm, Tm no and Tm pp are detailed in Supplementary Table 1.
Mutagenesis reactions were designed to incorporate three increasing levels of
mutagenic variation (low, medium and high) into each of the three gene fragments.
Each mutagenesis reaction of 25 ml contained 10 ng of central plasmid, 0.4 mM
primer mixture, 400mM dNTPs, 4% DMSO and 0.5 units of Phusion High-Fidelity
polymerase. The PCR cycles were initiated at 98 C for 3min to denature the
template DNA, followed by 18 ampliﬁcation cycles (program: 98 C, 1min; 50 C,
1min; 68 C, 5min (N- and C-terminal fragments)/11min (central fragment); and
ﬁnal extension at 68 C, 10min). Following mutagenesis, 5 ml of each PCR reaction
was analysed by agarose gel electrophoresis on a 1% TAE agarose gel containing
0.05% ethidium bromide. Reactions that contained a single band at the correct
size were treated with 10 units of DpnI at 37 C for 2 h. An aliquot of 2 ml of
each PCR product was transformed into 20 ml E. coli XL-10 Gold Ultracompetent
cells (Agilent) by heat-shock. For individual mutants, the transformed cells
were spread on a Luria-Bertani (LB) plate containing antibiotics and incubated at
37 C overnight. For mutant mixtures, the transformed cells were added directly to
liquid LB media containing antibiotics and incubated at 37 C overnight with
shaking at 230 r.p.m. Positive mutants were identiﬁed by sequencing puriﬁed
plasmid DNA.
SCOPE fragment ampliﬁcation. Before BFS gene reconstruction, mutagenized
N-terminal and C-terminal gene fragments were ampliﬁed by PCR using the
mutagenized N- and C-terminal plasmid library mixtures as a template. Speciﬁc
recombination primers and generic ampliﬁcation primers were designed as
described in Dokarry et al.17 (Supplementary Table 1). PCR was carried out using
Phusion High-Fidelity polymerase (98 C for 3min, followed by 30 cycles of 98 C
for 15 s, 50 C for 30 s, 72 C for 1min and 72 C for 10min) Each reaction was
veriﬁed by agarose gel electrophoresis on a 2% TAE agarose gel, and fragments
were diluted 1:10 for use in the SCOPE recombination reaction.
SCOPE library recombination. To recombine the full-length BFS gene, diluted
N-terminal and C-terminal fragments were mixed together in a 1:1 ratio and
recombined with 1 nM of the central fragment plasmid. For the N- and C-terminal
fragments, there were three sets of fragment mixtures with increasing levels of
mutagenic variation. These were mixed in a 1:1 ratio in a grid, as shown in
Supplementary Table 4b. Then 1 nM of the central fragment plasmid mixture was
added to each of the N-terminal and C-terminal fragment mixtures. The reaction
was set up as described in Dokarry et al.17 Recombination PCR was carried out
using Phusion High-Fidelity polymerase (98 C for 3min, followed by 30 cycles of
98 C for 15 s, 50–70 C ramp (50 C at cycle 1, then þ 1.5 C per cycle) for 30 s,
72 C for 30 s). Reactions were placed on ice and used directly in the SCOPE
ampliﬁcation reaction.
SCOPE library ampliﬁcation. Following gene recombination to assemble the BFS
gene, the full-length gene was ampliﬁed using 2.5ml of the recombination reaction as
a template for the SCOPE ampliﬁcation reaction. The reaction was set up as
described in Dokarry et al.17 PCR was carried out using Phusion High-Fidelity
polymerase (98 C for 3min, followed by 30 cycles of 98 C for 15 s, 65 C for
15 s, 72 C for 1min and 72 C for 10min). Reaction products were PEG precipitated
into the same volume of Tris-EDTA buffer, pH 8.0 (TE buffer) before Gateway
cloning.
Cloning of individual mutants. For individual mutants, Gateway cloning was
carried out in 5 ml reactions. pDONR207 and pH9GW were used as the entry
vector and destination vector, respectively. A 1 ml portion of the BP or LR reaction
was transformed into 10ml E. coli DH5a Library Efﬁciency cells (Life Technologies)
by heat-shock. The transformed cells were spread on LB plates containing anti-
biotics and incubated at 37 C overnight. Sequencing of BP clones was used to
identify correctly sequenced mutants to proceed to the LR reaction. For protein
expression, pH9GW plasmids were transformed into 5 ml E. coli BL21(DE3) cells
(NEB) by heat shock. Following cell recovery in 100 ml Super Optimal Broth (SOC),
10 ml of transformed cells were spread on LB plates containing antibiotics and
incubated at 37 C overnight.
Cloning of mutant mixtures. For mutant mixtures, Gateway cloning was carried
out in 5 ml reactions. The entire BP or LR reaction was transformed into 50 ml
E. coli DH5a Library Efﬁciency cells by heat-shock. The transformed cells were
added directly to liquid LB media containing antibiotics and incubated at 37 C
overnight with shaking at 230 r.p.m. For protein expression, expression plasmids
were transformed into 25 ml E. coli BL21(DE3) cells by heat-shock. Following cell
recovery in 250 ml SOC, the transformed cells were added directly to liquid LB
media containing antibiotics and incubated at 37 C overnight with shaking at
230 r.p.m.
Protein expression of mutants (library screening). Mutant mixtures in
BL21(DE3) cells from each of the nine pools were spread onto LB plates with
kanamycin, to isolate individual colonies each containing a single unique mutant.
Individual colonies were transferred to 2.5ml liquid media (LB with kanamycin) in
24-well plates and incubated overnight with shaking at 37 C at 230 r.p.m. A 0.5ml
of each overnight culture was diluted to 5ml with Terriﬁc broth (TB) growth media
with kanamycin in 24-well round bottom plates covered with micro-porous tape,
followed by growth with shaking at 37 C at 180 r.p.m. until cultures reached
OD600Z0.8. Protein expression was induced by addition of IPTG to 0.1mM
followed by growth with shaking at 20 C at 180 r.p.m. for 5 h. Cells were harvested
by centrifugation and cell pellets were frozen at  20 C.
Ni-NTA chromatography puriﬁcation of library proteins. Pellets from 5ml
expression cultures were re-suspended by adding 0.8ml of lysis buffer (50mM
Tris-HCl, 500mM NaCl, 20mM imidazole, 10% glycerol (v/v), 10mM
b-mercaptoethanol, and 1% (v/v) Tween-20, pH 8) containing 1mgml 1
lysozyme and 1mM EDTA directly to frozen pellets followed by shaking at room
temperature at 250 r.p.m. for 30min. Subsequently, 10 ml of benzonase solution
(850mM MgCl2 and 3.78U ml 1 benzonase (Novagen) was added followed by
additional shaking at 250 r.p.m. for 15min. The lysate was passed through a
Whatman uniﬁlter 96-well plate and collected in another Whatman plate con-
taining 50ml bed-volume of superﬂow Ni-NTA resin (QIAgen), pre-equilibrated
with lysis buffer using a vacuum manifold. Each well was washed with 1.5ml lysis
buffer (3 500 ml), followed by 1.5ml wash buffer (lysis buffer lacking Tween-20).
Resin was air-dried before addition of 150 ml elution buffer (wash buffer containing
250mM imidazole), followed by centrifugation at 1,500 r.p.m. for 2min to recover
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eluted protein. Protein concentration was measured using the Bradford Microassay
protocol.
Enzyme vial assay. The assay was performed as previously described42 in 2ml
screw-top glass vials (Agilent) in 500 ml reaction volume. Each reaction consisted of
assay buffer at pH 7.0 [25mM 2-(N-morpholino)ethanesulfonic acid (MES),
25mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), 50mM
Tris(hydroxymethyl)aminomethane (Tris)], 5mM MgCl2, 100mM farnesyl
diphosphate (FPP) and enzyme (1.5–3 mM). Reactions were mixed and overlaid
with 500 ml hexane (Sigma), and the caps were afﬁxed. After an overnight
incubation at room temperature, the hydrocarbon products were extracted by
vortexing for 10 s, followed by GC–MS analysis42.
Product identiﬁcation and quantiﬁcation by GC–MS. Reaction products were
analysed using a Hewlett–Packard 6890 gas chromatograph (GC) coupled to a 5973
mass selective detector (MSD) outﬁtted with a 7683B series injector and auto-
sampler and equipped with either an HP-5MS capillary column (5% diphenyl/95%
dimethyl siloxane) for standard separations or an HP-Chiral-20B column (20% b-
cyclodextrin) for chiral resolution (0.25mm i.d. 30m; 0.25 mm ﬁlm dimensions)
(Agilent). The GC was operated at a He ﬂow rate of 0.8mlmin 1, and the MSD
was operated at 70 eV. Splitless injections of 2 ml were performed with an injector
temperature of 250 C. Initial oven temperature of the GC was 80 C (1min hold),
which was then increased 20 C/min up to 140 C (1min hold), followed by a
5 Cmin 1 ramp until 170 C (2min hold), followed by a 100 Cmin 1 ramp
until 300 C (1min hold). A solvent delay of 6min was allowed before the
acquisition of MS data. For chiral separations, GC was operated at a He ﬂow rate of
1.5mlmin 1 with an injector temperature of 200 C. Initial oven temperature of
the GC was 50 C (5min hold), which was then increased 10 Cmin 1 up to
180 C (4min hold), followed by a 100 Cmin 1 ramp until 240 C (1min hold).
A solvent delay of 8.5min was allowed before the acquisition of MS data. Product
peaks were quantiﬁed by integration of peak areas using Enhanced Chemstation
(version E.02.00, Agilent Technologies). Products were identiﬁed using Massﬁnder
4.25 (http://massﬁnder.com/). Identiﬁed products were compared with known
terpenes in A. annua43,44.
The GC–MS data were inspected to identify the peaks (compounds) to be
quantiﬁed in the series of samples. The quantiﬁcation was carried out automatically
and used the mass spectra to obtain chromatograms extracted for ions (m/z)
(usually 3–5) speciﬁc to each compound. First the intensities of each extracted
chromatogram were calculated using Met-Idea v2.05 (ref. 45), based on a collection
of [retention time, m/z] pairs (Supplementary Table 13). The rest of the steps were
carried out in Matlab 2013 (The MathWorks) using scripts written in-house. For
each extracted chromatogram, the intensities were corrected to take into account
the percentage signal that the ion represented in the mass spectrum, so that the
corrected intensities should be the same for all ions and represent the amount
compound present (relative quantitation). These intensities were averaged across
ions. The percentage signal represented by each compound was then calculated. In
addition a report, from scripts written in house, was generated that provided a
number of useful diagnostic tools, notably graphs showing the extracted
chromatograms over the relevant RT range, as well as the correlation between the
corrected intensities from different ions. These were used to detect systematic bias
resulting from non-speciﬁcity and/or interference between closely eluting
compounds. When necessary the list of ions was reﬁned so as to limit such
occurrences.
Malachite green assay for kinetic measurements. Kinetic assays were per-
formed as described18 using 96-well ﬂat-bottomed plates (Grenier). For kcat
apparent measurements, assays of 50 ml were conducted in malachite green assay
buffer (vial assay buffer containing 2.5mU of the coupling enzyme inorganic
pyrophosphatase) from C. cerevisiae (Sigma) using six twofold serial dilutions of
puriﬁed protein. Monophosphate (Pi) and pyrophosphate (PPi) standard curves
(100 to 0.01 mM) were generated using a twofold serial dilution in malachite green
assay buffer without FPP. Reactions were set up in duplicate and incubated at room
temperature for 30, 90 and 180min. Enzyme reactions were quenched by addition
of the malachite green development solution (prepared according to Pegan et al.46),
incubated for 15min and then read at 623 nm on a Varioskan Flash plate reader18.
For steady-state kinetic measurements, assays of 50 ml were conducted in
malachite green assay buffer, and serial dilutions of FPP, with a starting
concentration of 100 mM. Enzyme was added to give a ﬁnal concentration of
0.014 mM, unless otherwise stated. Standard curves of monophosphate (Pi) and
pyrophosphate (PPi) (50 to 0.01 mM) were generated as above. Reactions were set
up on ice in triplicate and incubated at 30 C for 15 or 40min, depending on the
mutant studied. Enzyme reactions were quenched and read at 623 nm as above.
Calculations of minimal ﬁtness landscapes. We quantiﬁed the magnitude of
epistatic interactions between substitutions through a commonly used measure of
roughness24,47. A pure additive limit was calculated using a multidimensional
linear model26. A convenient measure of epistasis is a ratio of roughness to slope.
This ratio measures how well the landscape can be described by a linear model,
which corresponds to the purely additive (or non-epistatic) landscape. A
multidimensional linear model was ﬁtted to our ﬁtness landscapes by means of a
least-squares ﬁt. The ruggedness was calculated via the roughness to slope ratio
(r/s), using the linear model as described by Szendro et al.26 Each mutant was
represented by a binary string b¼ (b1,b2,y,bL) of length L, where bi¼ 0(1) if the
mutation at the i-th position is absent or present. The model is:
f fit bð Þ ¼
XL
j¼1
ajbjþ c ð1Þ
where the ﬁtting parameters are c and aj (coefﬁcients). The mean slope,
equation (2), was found by averaging the absolute of the ﬁtted coefﬁcients aj’s:
s ¼ 1
L
XL
j¼1
aj
  ð2Þ
and the roughness, equation (3), was deﬁned as:
r ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2 L
X
b
f bð Þ f fit bð Þ 2s ð3Þ
The higher the r/s ratio, the higher the roughness, which leads to more
deviation from the linear model and suggesting that more epistasis is present in the
landscape. For a purely additive smooth landscape, r/s¼ 0. We have used the scaled
values of cyclization percentage as a proxy for ﬁtness. We compare the roughness
and the r/s ratio between A. annua BFS and C. junos BFS in Table 2.
Fourier analysis of ﬁtness landscapes. Fourier analysis was performed using the
formulation by Szendro et al.26 and Zanini and Neher48. A function that maps a
binary string b to ﬁtness can be written as an expansion in terms of main effects
and interaction between the three sites:
F bð Þ ¼ FWT þ
XL¼3
i¼1
að1Þi bi þ
X
ioj
bibja
ð2Þ
ij þ
X
iojok
bibjbka
ð3Þ
ijk ð4Þ
where biA{0,1} denotes the mutation variant to indicate the absence or presence of
a mutation at a site. The ﬁrst order coefﬁcient a(1) in the expansion captures the
linear, non epistatic effects. The second order coefﬁcient a(2) describes the pairwise
epistatic interaction and a(3) denotes three-way epistatic interaction. In total there
are 2L coefﬁcients, we can simply ﬁnd them by solving a system of linear equations.
We used the relative ﬁtness values for the estimation of various epistatic measures
and to infer coefﬁcients of the expansion (Supplementary Table 12). Coefﬁcients
calculated in the biA{0,1} basis were used to ﬁnd the epistatic free reference
landscape by summing-up only the constant and ﬁrst order terms while predicting
the ﬁtted landscape (Fig. 6), equivalent to setting the second and third order
coefﬁcients to vanishingly small or zero. We also calculated the coefﬁcients of the
transform in the biA{ 1,þ 1} basis to calculate quantities Fsum, F1, F2 and F3 as
deﬁned in Szendro et al.26 For a purely additive, non-epistatic landscape we expect
that Fsum¼ 0 and F1¼ 1. The ﬁtted Fourier coefﬁcients and contribution of
epistasis orders are listed in Supplementary Table 12.
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